Impact of cause of death adjudication on the results of the European prostate cancer screening trial

BACKGROUND: The European Randomised Study of Prostate Cancer Screening has shown a 21% relative reduction in prostate cancer mortality at 13 years. The causes of death can be misattributed, particularly in elderly men with multiple comorbidities, and therefore accurate assessment of the underlying c...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Br J Cancer
Asıl Yazarlar: Walter, Stephen D, de Koning, Harry J, Hugosson, Jonas, Talala, Kirsi, Roobol, Monique J, Carlsson, Sigrid, Zappa, Marco, Nelen, Vera, Kwiatkowski, Maciej, Páez, Álvaro, Moss, Sue, Auvinen, Anssi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 2017
Konular:
Epidemiology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5220145/
https://ncbi.nlm.nih.gov/pubmed/27855442
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.378
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller